-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

Benzinga·08/14/2026 18:54:51
语音播报
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $13.